---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-119847"
form_type: "8-K"
ticker: "CDXS"
cik: "0001200375"
company_name: "CODEXIS, INC."
filed_at: "2025-05-14T23:59:59+00:00"
generated_at: "2026-05-21T08:00:30.901849+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Codexis Q1 revenue drops to $7.5M from $17.1M; net loss widens to $20.7M

## Summary
- Revenue $7.5M vs $17.1M in Q1 2024; decline due to $6M one-time Roche license and large orders in prior year.
- Net loss $20.7M ($0.25/share) vs $11.5M ($0.16/share) in Q1 2024; R&D expenses up to $12.9M.
- Cash $59.8M; expects to fund operations through positive cash flow by end 2026.
- Reiterates FY 2025 revenue guidance of $64M-$68M; secured first revenue contract for ECO Synthesis manufacturing.
- Appointed Christos Richards and Cynthia Collins to board; Arthur Levin to Strategic Advisory Board.

## SEC filing metadata
- accession: 0001193125-25-119847
- form_type: 8-K
- ticker: CDXS
- cik: 0001200375
- company_name: CODEXIS, INC.
- filed_at: 2025-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1200375/000119312525119847/0001193125-25-119847-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1200375/000119312525119847/d949323d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-119847
- JSON: https://secwatch.observer/filing/0001193125-25-119847.json
- Plain text: https://secwatch.observer/filing/0001193125-25-119847.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.